Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AL-37807 in Open-Angle Glaucoma or Ocular Hypertension
NCT00372931Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- May 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of AL-37807 in open-angle glaucoma (OAG) and ocular hypertension, sponsored by Alcon Inc. Primary endpoint: Mean IOP change from baseline. Started May 2006; status: completed.
02
Drugs
AL-37807
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00372931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00372931.